Table 2 Summary of the most frequent anatomical pathologies observed
Organs and associated pathologies | Controls | GMO 11% | GMO 22% | GMO 33% | R (A) | R (B) | R (C) | GMO 11% + R | GMO 22% + R | GMO 33% + R |
|---|---|---|---|---|---|---|---|---|---|---|
Males | ||||||||||
Kidneys, CPN | 3 (3) | 4 (4) | 5 (5) | 7 (7) | 6 (6) | 5 (5) | 3 (3) | 5 (5) | 4 (4) | 4 (4) |
Liver | 2 (2) | 5 (4) | 11 (7) | 8 (6) | 11 (5) | 9 (7) | 6 (5) | 5 (4) | 7 (4) | 6 (5) |
Hepatodigestive tract | 6 (5) | 10 (6) | 13 (7) | 9 (6) | 23 (9) | 16 (8) | 9 (5) | 9 (6) | 13 (6) | 11 (7) |
Females | ||||||||||
Pituitary | 9 (6) | 23 (9) | 20 (8) | 8 (5) | 22 (8) | 16 (7) | 13 (7) | 19 (9) | 9 (4) | 19 (7) |
Mammary glands | 10 (5) | 22 (8) | 10 (7) | 16 (8) | 26(10) | 20(10) | 18 (9) | 17 (8) | 16 (8) | 15 (9) |
Mammary tumors | 8 (5) | 15 (7) | 10 (7) | 15 (8) | 20 (9) | 16(10) | 12 (9) | 10 (6) | 11 (7) | 13 (9) |